We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+2.26%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$3.43B
AUM Growth
-$3.53B
(-51%)
Cap. Flow
-$6.14B
Cap. Flow
% of AUM
-178.75%
Top 10 Holdings %
Top 10 Hldgs %
20.05%
Holding
4,637
New
1,031
Increased
432
Reduced
2,408
Closed
565
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$122M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$91.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$58.4M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$56.3M |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$52.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 100 ETF
OEF
|
+$2.6B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.29B |
| 3 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$211M |
| 4 |
American Century Diversified Corporate Bond ETF
KORP
|
+$153M |
| 5 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$148M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.28% |
| 2 | Financials | 5.08% |
| 3 | Healthcare | 4.17% |
| 4 | Consumer Discretionary | 3.04% |
| 5 | Industrials | 2.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Edgewise Therapeutics
EWTX
$4.13B
| $2.16K | ﹤0.01% |
87
-19
| -18% | -$381 |
|
3227
Agios Pharmaceuticals
AGIO
$1.82B
| $2.15K | ﹤0.01% |
79
-623
| -89% | -$21.9K |
|
|
PRA
3228
DELISTED
ProAssurance
PRA
| $2.15K | ﹤0.01% |
89
-319
| -78% | -$7.67K |
|
|
AWF
3229
AllianceBernstein Global High Income Fund
AWF
$874M
| $2.14K | ﹤0.01% |
200
| – | – |
|
|
BBT
3230
Beacon Financial Corp
BBT
$2.69B
| $2.14K | ﹤0.01% |
81
-20,479
| -100% | -$519K |
|
3231
BOK Financial
BOKF
$8.74B
| $2.13K | ﹤0.01% |
18
-805
| -98% | -$90.3K |
|
|
SLNO
3232
DELISTED
Soleno Therapeutics
SLNO
| $2.13K | ﹤0.01% |
46
-23
| -33% | -$1.26K |
|
3233
iRhythm Holdings
IRTC
$4.1B
| $2.13K | ﹤0.01% |
12
-120
| -91% | -$21.3K |
|
3234
Sierra Bancorp
BSRR
$524M
| $2.13K | ﹤0.01% |
65
-1,069
| -94% | -$32.3K |
|
|
AAMI
3235
Acadian Asset Management
AAMI
$3.2B
| $2.12K | ﹤0.01% |
45
-566
| -93% | -$26.1K |
|
3236
Enliven Therapeutics
ELVN
$4.15B
| $2.11K | ﹤0.01% |
137
-16
| -10% | -$319 |
|
3237
Lightpath Technologies
LPTH
$702M
| $2.08K | ﹤0.01% |
193
+119
| +161% | +$964 |
|
3238
Beam Therapeutics
BEAM
$2.67B
| $2.08K | ﹤0.01% |
+75
| New | +$1.91K |
|
3239
Frontdoor
FTDR
$5.34B
| $2.08K | ﹤0.01% |
36
-3,578
| -99% | -$210K |
|
3240
Playtika
PLTK
$1.54B
| $2.07K | ﹤0.01% |
524
-33,384
| -98% | -$131K |
|
3241
Ribbon Communications
RBBN
$379M
| $2.07K | ﹤0.01% |
718
-3,336
| -82% | -$10.8K |
|
3242
Samsara
IOT
$21.6B
| $2.06K | ﹤0.01% |
58
-26
| -31% | -$1.01K |
|
3243
Fulcrum Therapeutics
FULC
$283M
| $2.05K | ﹤0.01% |
+181
| New | +$1.84K |
|
|
NTST
3244
NETSTREIT Corp
NTST
$2.08B
| $2.05K | ﹤0.01% |
116
-1,985
| -94% | -$36.1K |
|
3245
Caledonia Mining Corp
CMCL
$363M
| $2.04K | ﹤0.01% |
78
-140
| -64% | -$4.12K |
|
3246
National Vision
EYE
$1.8B
| $2.04K | ﹤0.01% |
79
-513
| -87% | -$13.8K |
|
3247
DoubleVerify
DV
$1.8B
| $2.04K | ﹤0.01% |
178
-61,623
| -100% | -$680K |
|
3248
iShares US Pharmaceuticals ETF
IHE
$1.61B
| $2.04K | ﹤0.01% |
+24
| New | +$1.92K |
|
3249
Evolus
EOLS
$398M
| $2.03K | ﹤0.01% |
305
+300
| +6,000% | +$2.03K |
|
3250
Louisiana-Pacific
LPX
$5.15B
| $2.02K | ﹤0.01% |
25
-7,921
| -100% | -$669K |
|
Similar funds
TYCC
TH
ACA
BCP
WWA
VPC
BPS
TCM
Arax Advisory Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Arax Advisory Partners held 4,637 positions worth $3.43B, down 51% from $6.97B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arax Advisory Partners withdrew a net $6.14B in Q4 2025, closing 565 positions and reducing 2,408 holdings. Its most notable exit was State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF, an estimated $39M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arax Advisory Partners opened a new position in Vanguard Morningstar Growth ETF worth $122M.
- Arax Advisory Partners's largest Q4 2025 buy was Vanguard Morningstar Growth ETF: 1,504,890 shares worth $122M.
- Arax Advisory Partners added most to Vanguard Total International Stock ETF in Q4 2025, an estimated $13M increase.
- Arax Advisory Partners's biggest Q4 2025 reduction was iShares S&P 100 ETF, cutting an estimated $2.6B.
- Arax Advisory Partners fully exited State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF in Q4 2025, selling an estimated $39M.
- Arax Advisory Partners's ten largest holdings make up 20% of its $3.43B portfolio in Q4 2025.
- Arax Advisory Partners opened 1,031 new positions and closed 565 in Q4 2025.
- Arax Advisory Partners's portfolio value fell 51% quarter-over-quarter to $3.43B.
Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.